下载
Anti-Human IL‑23 p19 Reference Antibody (Risankizumab, RUO)
Overview
Catalog No. HV466016
Brand abinScience
Host species Human
Tested applications WB
Species reactivity Human
Form Liquid
Storage buffer 0.01M PBS pH 7.4.
Purity >95% as determined by SDS-PAGE.
Clonality Monoclonal
Isotype IgG1-kappa
Applications ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Target IL-23 subunit alpha, IL-23-A, IL-23p19, IL23A, Interleukin-23 subunit alpha, Interleukin-23 subunit p19, SGRF
Purification Protein A/G purified from cell culture supernatant.
Endotoxin level < 10 EU/mg as determined by LAL method.
Accession Q9NPF7
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative nameBI655066, risankizumab-rzaa, 1612838-76-2
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
Images


Bioactivity
SEC-HPLC detection for Research Grade Risankizumab.

SDS-PAGE
SDS-PAGE for Research Grade Risankizumab.

Bioactivity
Detects IL23A in indirect ELISA

Western blot
Western blot analysis was performed using anti-IL23A monoclonal antibody at 1ug/mL on various samples.
Lane 1: recombinant human IL23A (Catalog No: HV466011)
Lane 2: negative control